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Abstract.  Using either permeabilized cells or micro- 
somes we have reconstituted the early events of the 
yeast secretory pathway in vitro. In the first stage of 
the reaction ,'o50-70%  of the prepro-ct-factor,  synthe- 
sized in a yeast translation lysate, is translocated into 
the endoplasmic reticulum (ER) of permeabilized yeast 
cells or directly into yeast microsomes. In the second 
stage of the reaction 48-66 % of the ER form of 
a-factor (26,000 D) is then converted to the high mo- 
lecular weight Golgi form in the presence of ATP,  sol- 
uble factors and an acceptor membrane fraction; 
GTPyS inhibits this transport reaction.  Donor, accep- 
tor, and soluble fractions can be separated in this as- 
say.  This has enabled us to determine the defective 
fraction in sec23, a  secretory mutant that blocks ER to 
Golgi transport in vivo. When fractions were prepared 
from mutant cells grown at the permissive or restric- 
tive temperature and then assayed in vitro, the accep- 
tor Golgi fraction was found to be defective. 
T 
hE  transit of newly synthesized proteins  along the 
secretory pathway involves a number of events which 
have been defined biochemically or morphologically. 
After synthesis in the cytoplasm and entry into the lumen of 
the endoplasmic reticulum (ER) 1, proteins are modified by 
cleavage of the signal sequence, glycosylated, and assume 
their native conformation (Blobel and Dobberstein,  1975; 
Kornfeld and Kornfeld, 1985). Morphological and cell frac- 
tion studies have suggested that the exit of proteins, from the 
lumen of the ER, is mediated by vesicles which bud from 
transitional  elements  and  fuse  with  the  Golgi  complex 
(Palade, 1975; Farquhar and Palade, 1981; Saraste and Kuis- 
manen,  1984;  Saraste and Hedman,  1983;  Saraste et al., 
1986;  Lodish et al.,  1987).  Although the earliest events of 
protein  transport  have  been  reconstructed  biochemically 
(Walter et al.,  1984),  later events such as the formation, 
transport, and fusion of shuttle vesicles with the Golgi com- 
plex are not well understood. 
In vitro assays have proven to be  an important tool in 
analyzing complicated biological processes. A biochemical 
dissection of the secretory pathway will require the develop- 
ment of transport assays that reconstitute stages of this path- 
way in vitro. This approach has already led to the identifica- 
tion of several components that play a role in the transit of 
proteins through the cell. For example, eukaryotic in vitro 
translocation systems, that reproduce the events involved in 
the targeting and threading of  proteins across the lipid bilayer 
1. Abbreviations usedin thispaper: Endo H, endoglycosidase  H; ER, endo- 
plasmic reticulum.  HSP, high speed pellet;  HSS, high speed supernatant; 
Pic, protease inhibitor cocktail. 
of the ER membrane, have permitted the identification of 
several  components involved in  this  process  (Walter  and 
Blobel,  1980;  Meyer et al.,  1982;  Wiedmann et al.,  1987; 
Waters et al., 1986). More recently, an assay that can mimic 
inter-Golgi transport in vitro (Balch et al., 1984), has led to 
the identification of an N-ethylmaleimide-sensitive protein 
involved in a later stage of the pathway (Glick and Rothman, 
1987). Although specific factors which mediate intracellular 
protein transport between the ER and the Golgi complex re- 
main to be discovered, in vitro transport assays that use per- 
meabilized mammalian cell systems suggest that they exist. 
With this approach (Simons and Virta, 1987; Beckers et al., 
1987)  cells are  radiolabeled with [35S]methionine,  during 
infection with vesicular stomatitis virus, either before or af- 
ter the cells are permeabilized. In the presence of an ATP 
regenerating system presynthesized G protein, a membrane 
glycoprotein residing in the ER, is transported to the Golgi 
complex as indicated by trimming of the ER-associated high 
mannose oligosaccharide form of G protein. 
A molecular dissection of the events in intracellular pro- 
tein transport would be facilitated by an analysis of the secre- 
tory pathway in  an  organism that is  amenable to  both a 
genetic and biochemical approach. The yeast Saccharomy- 
ces cerevisiae offers this advantage. The genetic flexibility of 
this organism has permitted the isolation of a large collection 
of mutants that block protein transport at various stages  of 
the pathway. Of the many genes that have been implicated in 
these processes, mutations in 11 genes (called SEC or BET) 
have been shown to affect the transit of proteins from the lu- 
men of the ER to the Golgi complex (Novick et al.,  1980; 
Newman and Ferro-Novick, 1987). At 37°C (nonpermissive 
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transported in these mutants, accumulate in the lumen of the 
ER. An assay that efficiently reconstitutes protein transport 
from the ER to the Golgi complex in vitro could elucidate 
the  molecular  defect  in  these  mutants  and  lead  to  the 
identification of components that play an essential role in this 
process. 
Here we introduce a new assay that uses translocation into 
microsomes,  or  the  ER  of permeabilized  yeast  cells,  to 
reconstitute transport to the  Golgi complex.  A  precursor 
form (prepro-a-factor) of the secreted pheromone a-factor 
serves as a marker protein in this assay. In vivo (Julius et al., 
1984b), this protein receives three N-linked oligosaccharide 
chains  (Glucose3  Mannose9  N-acetylglucosamine2) in  the 
ER and is further modified by an extensive addition of man- 
nose units (outer chain carbohydrate) in the Golgi complex. 
In the transport assay we developed, these posttranslational 
modifications are performed in vitro. The passage of prepro- 
a-factor to the Golgi complex is assayed in two stages. In the 
first stage of the reaction preproprotein of high specific ra- 
dioactivity is synthesized in vitro and is translocated into the 
lumen of the ER. Translocation can be achieved in two ways: 
by using either a permeabilized cell system or yeast micro- 
somes. In the second stage of the reaction the ER form of 
a-factor is transported to the Golgi complex. Transit is de- 
tected by the addition of outer chain carbohydrate. In this re- 
port we show that reconstitution of transport from the ER to 
the Golgi complex in yeast is dependent upon the presence 
of ATP and a 3,000 g supernatant ($3) of a yeast lysate. This 
supernatant contains both soluble factor(s) and membrane- 
bound components that include the acceptor compartment. 
Furthermore we have demonstrated that an $3 fraction iso- 
lated from sec23, a mutant that blocks ER to Golgi transport 
in vivo, fails to support transport in vitro. Fractionation of 
this supernatant has shown that a defect in the Sec23 protein 
destroys the activity of acceptor membranes without affect- 
ing the soluble factors required for transport. 
Materials and Methods 
Growth Conditions 
Yeast used for the preparation of permeabilized cells and $3 fractions were 
grown at 25°C in YPD medium (1% yeast extract, 2% Bactopeptone, and 
2 % glucose) to an ODs99 =  1.5-4.0. Wickerham's minimal medium (1946) 
was used; for sulfate-free medium, all sulfate salts were replaced by chloride 
salts. To change growth medium, cells were harvested in a  clinical cen- 
trifuge at room temperature and then resuspended in new medium. Cell den- 
sities were measured in a 1-cm quartz cuvette at 599 nm in a spectrophotom- 
eter (model 25;  Beckman Instruments, Inc., Palo Alto, CA). 
Preparation of  Permeabilized Cells, $3, High Speed 
Supernatant (HSS) and High Speed Pellet (lISP) 
Fractions 
Cells grown at 25°C were harvested and resuspended in YP medium con- 
taining 0.1%  glucose (OD599 =  1.5).  After a 30-min incubation at 24°C, 
cells (150 OD599 units) were pelleted, resuspended in 50 ml of spheroplast- 
ing medium (YP medium, 0.1% glucose, 50 mM potassium phosphate, 1.4 
M sorbitol, 50 mM [$-mercaptoethanol, pH 7.5, and 1 mg Zymolyase 100T 
[ICN Immunobiologicals, Plainview, NY]) and incubated at 370C for 30 
min (or 60 min at 24°C for the sec23 permissive experiment). Spheroplasts 
formed during this time were incubated in 100 ml of regeneration medium 
(YP medium, 0.1% glucose and 1 M  sorbitol) for 90 min at 37°C (or 90 
min  at  24°C  for  the  sec23  permissive  experiment).  The  regenerated 
spheroplasts were split into two equal aliquots; an $3 fraction was prepared 
from one aliquot and permeabilized cells were generated from the remain- 
ing portion. To prepare the permeabilized cells, the regenerated spbero- 
plasts were harvested, resuspended in 5 ml of  permeabilization buffer (0.1 M 
potassium acetate, 0.2 M sorbitol, 2 mM magnesium chloride, and 1/50 vol 
of 1 M  Hepes [pH 7.2]), and centrifuged at 3,000 g for 5 rain. The final 
pellet was resuspended in 50 lxl of buffer I (250 mM sucrose, 2 mM dithio- 
threitol [DTT],  1 mM EGTA, and 1/50 vol of 1 M Hepes [pH 7.4])  sup- 
plemented with Ix Protease inhibitor cocktail (Pie; described by Waters and 
Blobel, 1986). To prepare the $3 fraction, the regenerated spheroplasts were 
resuspended in 206 I~1 of 20 mM Hepes (pH 7.2) and then centrifuged at 
3,000 g for 5 min. The HSS and HSP fractions were generated from an $3 
fraction (supplemented with Ix  Pic) centrifuged at 100,000 g for 1 h; the 
pellet (HSP) was resuspended in an equal volume of  20 mM Hepes (pH 7.2). 
Before the transport assay-concentrated Hepes buffer, potassium acetate, 
magnesium chloride, and sorbitol were added to the $3, HSS, and HSP frac- 
tions. The final concentration of buffer in each fraction was: 115 mM potas- 
sium acetate, 2.5 mM magnesium chloride, 0.2 M sorbitol, Ix Pic, and 1/28 
vol of 1 M Hepes (pH 7.2).  The protein concentration of each fraction was 
measured using the Bradford assay (1976): permeabilized cells (19 mg/ml), 
$3 fraction (14 mg/ml), HSS (8 mg/ml), and HSP (6 mg/ml). Ovalbumin 
was used as a protein standard in this assay. 
In Vitro Translation and Translocation 
In vitro transcriptions, yeast translation lysates, and microsomes were pre- 
pared as described before (Hansen et al., 1986) with minor modifications, 
briefly summarized below.  20  t~g of plasmid pDJl00  (obtained from D. 
Julius) was linearized with Xba I (Boehringer Mannheim Diagnostics, Inc., 
Houston, TX) and then transcribed with S1Ri RNA polymerase. The RNA 
was precipitated and resuspended in 100 I~1 of water.  Cells (,'~4,000 OD599 
units), used to prepare yeast translation lysates, were converted to spbero- 
plasts during a 30-rain incubation at 37°C with 30 mgs of zymolyase 100T. 
The spheroplasts formed during this incubation were regenerated for 60 min 
at 37°C and then lysed as described by Hansen et al. (1986) with half the 
volume of lysis buffer. The lysate was homogenized with a motor driven Pot- 
ter homogenizer (40 strokes). Cells, used for the preparation of micro- 
somes, were converted to spheroplasts as described above with the regenera- 
tion step eliminated. The protocol of Hansen et al. (1986)  was used with 
minor modifications. The SI0 supernatant was loaded onto a sucrose cush- 
ion (2.0 M sucrose, 2 mM DTT,  2x  Pic, and 1/50 vol of 1 M Hepes [pH 
7.4]),  rather than a PercoU gradient, and centrifuged at 100,000 g for 1 h. 
The microsomes at the interface were collected, treated with Staphylococcal 
nuclease as described before (Hansen et al., 1986),  and washed by passage 
through a Sephacryl S-500 (Sigma Chemical Co., St. Louis, MO) column 
as described earlier (Walter  and Blobel,  1983). 
The translation cocktail (25 lxl/reaction)  contained 10 ~tl of  the translation 
lysate, 20 mM Hepes (pH 7.4),  150 mM potassium acetate, 3 mM mag- 
nesium acetate, 2.8 mM DTT,  1 mM ATP, 0.1 mM GTP, 20 mM cmatine 
phosphate,  30  IxM  of each  amino  acid  except methionine,  20  I,  tCi  of 
[3~S]methionine  tAmersham  Corp.,  Arlington  Heights,  IL;  1,000  Ci/ 
mmol), 0.2 mg/ml yeast tRNA (Boehringer Mannheim Diagnostics, Inc.), 
0.2 mg/ml creatine phosphate kinase, 10 U RNAsin (Promega Biotec, Madi- 
son, WI, 40,000  U/ml), 8% glycerol, 75 mM sucrose, lx Pic, and 3 ~tl of 
RNA (1/10 dilution of preparation described above). Prepro-tz-factor was 
translated in vitro during a 1-h incubation at 20°C. Permeabilized cells (60 
I.tg of protein) or microsomes (16 ~tg of protein in 3 121) were added to the 
lysate (supplemented with 20 mM creatine phosphate) and the reaction mix 
was incubated at 20°C for 20 min. The translocation reaction was termi- 
nated by chilling the samples on ice. The amount of prepro-ct-factor  translo- 
cated was determined by densitometric scanning (model GS 300;  Hoefer 
Scientific Instruments, San Francisco, CA) of light exposures of autoradio- 
grams from six different experiments. The values we obtained were in the 
linear range of the assay. The percentage of prepro-ct-factor  translocated was 
defined as the amount of 19-kD primary translation product converted to 
the 26-kD species. The sum of the untranslocated 19-kD species and the 
26-kD species was approximately equal to the 19-kD  primary translation 
product present before the translocation reaction was initiated. 
In Vitro Transport Reaction 
Permeabilized cells (60 I.tg of protein), containing radiolabeled proprotein 
in the lumen of the ER, were pelleted during a  15-s centrifugation in a 
microfuge. The cells were washed (25 Ill/reaction) with transport buffer (115 
mM potassium acetate, 2.5 mM magnesium chloride, 0.2 M sorbitol, lx 
Pic, and 1/50 vol of 1 M Hepes [pH 7.2l) and then resuspended in the same 
buffer (25  kd). The transport reaction (81.7 txl final volume unless stated 
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of an $3 fraction (0.7-1.0 mg of protein), 0.92 mM GDP-mannose (Sigma 
Chemical Co.), and an ATP-regenerating system (1 mM ATE 0.1 mM GTP, 
20 mM creatine phosphate, 0.2 mg/ml creatine phosphate kinase). The mix 
was incubated at 20°C for 90 min and the reaction was terminated by chill- 
ing the samples on ice. To deplete samples of ATE apyrase (5 U/ml, grade 
VIII, Sigma Chemical Co.) instead of the ATP-regenerating system, was 
added to the reaction mix. After the reaction, samples were immunoprecipi- 
tated with 2 lal of anti-a-factor antibody as described before (Ruohola and 
Ferro-Novick, 1987),  When using the ¢tl-6-Main antibody (obtained from 
C. Ballou), samples were first immunoprecipitated with anti-a-factor anti- 
body, washed as described before (Ruohola and Ferro-Novick, 1987) and 
solubilized in 70 t.tl of sample buffer at 100°C for 5 min. Samples were then 
diluted  as  described  earlier  (Ruohola  and  Ferro-Novick,  1987),  and 
reprecipitated with  10 p.I of ctl-6-Man antibody. Solubilized immunopre- 
cipitates were subjected to electrophoresis in a  12.5%  NaDodSOdpoly- 
acrylamide slab gel unless stated otherwise and fluorographed as described 
before (Chamberlain, 1979).  The decrease in the ER form of a-factor, ob- 
served during the transport reaction, was determined either by densitomet- 
ric  scanning of light  exposures of autoradiograms  or  by  excising and 
solubilizing protein bands from gels and measuring the counts by liquid 
scintillation counting as described before (Bangs et al.,  1986). 
Protease Protection 
Samples were incubated with trypsin (0.47  mg/ml) in the presence or ab- 
sence of 0.1% Triton X-100 during a 30-min incubation on ice. Trypsin in- 
hibitor (final concentration 0.94 mg/ml) was added, and after 5 min, sam- 
ples were boiled in  1%  SDS and then immunoprecipitated as described 
before (Ruohola and Ferro-Novick,  1987). 
Treatment with Endoglycosidase H (Endo H) 
Solubilized immunoprecipitates were resuspended in 85 ~tl of buffer A (100 
mM ammonium acetate  [pH  5.5],  0.45%  SDS,  3%  ~-mercaptoethanol, 
0.03%  sodium azide and 2×  Pic) and boiled for 5 min. Each sample was 
divided into two tubes containing 120 p.l of buffer B (100 mM ammonium 
acetate [pH 5.5], 3 % Triton X-100, 0.03 % sodium azide, and 2 x  Pie). Endo 
H (7.5 mU; ICN Immunobiologicals) was added to one of the two tubes and 
the samples were incubated at 37°C for 13 h. The reaction was terminated 
by the addition of 6 vol of acetone (20 p.g of cytochrome c was added as 
carrier protein). After a 2-h incubation at -20°C, samples were centrifuged 
for 15 min in a microfuge and the pellet was resuspended in sample buffer. 
Electron Microscopy 
Spheroplasts and permeabilized yeast cells (50 ODs99 units) were fixed for 
3.5  h  in  1%  paraformaldehyde, 0.8%  glutaraldehyde, 0.15  M  cacodylate 
buffer  (pH  7.2),  0.1  M  potassium  acetate,  0.2  M  sorhitol  (1  M  for 
spheroplasts), and 2 mM magnesium chloride. Samples were washed three 
times with 0.15 M cacodylate buffer (pH 7.2) and then postfixed for 1 h on 
ice with 1% osmium tetroxide, 0.1 M cacodylate buffer (pH 7.2).  Samples 
were then washed three times with 0.15 M sodium chloride and stained for 
2 h on ice with uranyl acetate in 0.5% sodium chloride. The samples were 
washed again with 0.15 M sodium chloride, resuspended in 2% Bacto-agar, 
and formed into blocks. The blocks were dehydrated with ethanol and em- 
bedded in Spurr medium (Polysciences, Inc., Warrington, PA).  Thin sec- 
tions were stained with uranyl acetate and lead citrate, then viewed in an 
electron microscope (model 301; Philips Electronic Instruments, Mahwah, 
NJ) at 80 kV. 
In Vivo Radiolabeling of  sec Mutants 
The mutants were grown overnight, at 25°C (ODs~  =  1-1.5),  in sulfate- 
free minimal medium supplemented with 100 I.tM ammonium sulfate and 
2 % glucose. For radiolabeling, a modification of the protocol described by 
Reid and Schatz (1982)  was used. Cells were resuspended in sulfate-free 
medium  containing  2%  glucose  (10D599  U/0.1  ml)  and  labeled  with 
[3SS]sulfate (200 p.Ci/ODs~) for 2 min during vigorous aeration. The incu- 
bation was terminated by the addition of 2.5 vol of cold ammonium sulfate 
(35 mM final concentration) and the cells were harvested and flash frozen 
in liquid nitrogen. Thawed cells were resuspended in 100 I.tl of 1% SDS and 
lysed by vortexing for 2 min, on a vortex mixer in the presence of glass beads 
(0.2 g of glass beads, 425-600 I.tm in size). The lysate was diluted as de- 
scribed before (Ruohola and Ferro-Novick, 1987) and immunoprecipitated 
with a-factor antibody. 
Immunoblot Analysis 
Spheroplasts were resuspcnded in permeabilization buffer and centrifuged 
at 3,000 g  for 5 min. The amount of earboxypeptidase Y and bexokinase 
B released into the supernatant and retained within the permeabilized cells 
was determined by Immunoblot analysis. Samples were subjected to elec- 
trophoresis in a  10%  NaDodSOdpolyacrylamide slab gel and then trans- 
ferred overnight at 4°C onto nitrocellulsoe (BA 83, 0.2 I~m Schleicher & 
Schuell, Keene, NH). Carboxypeptidase Y and bexokinase B were detected 
with antisera and radioiodinated staphylococcal protein A  (30  mCi/mg, 
Amersham Corp.) as previously described (Goud et al.,  1988).  Anti-car- 
boxypeptidase antiserum was used at a dilution of 1:400  and anti-hexo- 
kinase B antiserum was used at a dilution of 1:200. The nitrocellulose filters 
were dried and exposed to Kodak XAR-5 film at -70°C for 4-6 h. The pro- 
tein bands were excised from the nitrocellulose filter and counted in a 
Gamma counter (model 4000; Beckman Instruments, Fullerton, CA). The 
data points reported in Table II were in the linear range of the assay. 
Results 
Prepro-a-factor Enters Permeabilized Yeast Cells and is 
Translocated Across the ER Membrane 
To develop an efficient assay that can reconstitute the early 
events of protein transport in yeast, we used permeabilized 
yeast cells.  Permeabilized cells (SFNY26-6A,  see Table I) 
were prepared by removing the yeast cell wall enzymatically 
and  osmotically  shocking  spheroplasts.  Electron  micro- 
scopic  analysis of thin  sections  revealed that cytoplasmic 
contents were depleted from the permeabilized cells (Fig. 1, 
compare C with A and B).  Although holes in the plasma 
membrane were not visible, it appeared that this lipid bilayer 
no longer served as a barrier between contents normally re- 
tained within the cell and its environment. Nuclear contents 
were preserved in these cell preparations, however, the nu- 
clear envelope was dilated (Fig. 1 A). The dark granular ma- 
terial of the vacuole was also retained (Fig.  1 B).  Vesicles 
studded with ribosomes, seen at higher magnifications (not 
shown), were most likely derived from the ER membrane. 
To biochemically assay the extent of permeabilization, Im- 
munoblot analysis was used to quantitate the release of two 
different enzymes: hexokinase B, a cytoplasmic enzyme, and 
carboxypeptidase Y, a vacuolar constituent.  The results in 
Table  II  demonstrate that  most  of the  hexokinase B  was 
depleted from the permeabilized cells, while the maiority of 
the carboxypeptidase Y was retained in the cell preparations. 
Previous  studies  with  yeast have shown  that prepro-a- 
factor is  efficiently translocated across the ER membrane 
(Hansen et al., 1986; Rothblatt and Meyer, 1986; Waters and 
Blobel, 1986). Accordingly, we added permeabilized cells to 
a yeast lysate containing radiolabeled prepro-ct-factor trans- 
lated in vitro. As is evident from the results presented in Fig. 
2, A and B (lane 2), the 19-kD primary translation product 
entered these cells and was  efficiently translocated across 
the ER membrane.  Approximately 50-70%  of the prepro- 
a-factor was converted to the 26-kD ER form (three N-linked 
oligosaccharide units).  This form was protected from pro- 
teases in the absence of detergent (Fig. 2 A, lane 3), but was 
fully degraded in the presence of detergent (Fig. 2 A, lane 
4). Minor species containing 1 and 2 N-linked core oligosac- 
charide units were also observed (Fig. 2 B, lane 2) as previ- 
ously reported (Hansen et al.,  1986; Rothblatt and Meyer, 
1986; Waters and Blobel, 1986). This finding indicated that 
the ER membrane in these cell preparations was biologically 
active, intact and accessible to exogenously added substances. 
To determine if the ER form of a-factor was contained within 
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Strain  Genotype  Source 
SFNY  26-6A*  MAT a,  his 4-619  This study 
NY 429  MAT a,  ura 3-52,  secl4-3  P.  Novick~ 
NY 432  MAT a,  ura 3-52,  sec 18-1  P.  Novick 
LHY 3-8C  MAT a,  ura 3-52,  leu 2-3,  112  R.  Deshaies§ 
his 3,  sec23-1 
LB  1-3B  MAT a,  mnn 2-1  C.  Ballou§ 
LB 347-1C  MAT a,  mnn9  C.  Bailou 
* SFNY26-6A is essentially isogenic to DBY 877 (obtained  from D. Botstein, 
Department of Biology, Massachusetts Institute of Technology, Cambridge, 
MA). 
:~  Department  of Cell  Biology, Yale University  School of Medicine. 
§  Department  of Biochemistry, University  of California  at Berkeley, Berke- 
ley,  CA. 
the permeabilized cells after the translocation reaction, we 
sedimented the cells by performing a  15-s centrifugation in 
a microfuge. Since the majority of  the 26-kD form of a-factor 
was found to pellet (Fig. 2 B, lanes 2-4), it must have resided 
inside the permeabilized cells. 
The ER Form of a-factor is Converted to a 
High Molecular Weight Species in the Presence of  an 
$3 Fraction and ATP 
Transport  and  processing  of prepro-a-factor through  the 
yeast secretory pathway has  been previously examined in 
vivo (Julius et al.,  1984b). When the transit of this protein 
is arrested in the Golgi apparatus, the major form which ac- 
cumulates is a high molecular weight species that migrates 
as  a  heterogeneous  smear  on  SDS-polyacrylamide  gels 
(Julius et al.,  1984a). Analysis of this material has shown 
that this form of a-factor results from the addition of outer 
chain carbohydrate to the proprotein. Proteolytic processing 
is thought to begin in the Golgi complex and completed in 
secretory  vesicles.  Mature  ~t-factor  is  secreted  into  the 
medium as a  13 amino acid peptide (Julius et al.,  1984b). 
To determine if transport to the Golgi complex could occur 
in vitro, we pelleted the permeabilized yeast cells after the 
translocation reaction, and resuspended them in a buffer that 
contained an ATP regenerating system,  GDP-mannose  (a 
substrate  for mannosyltransferases;  Nakajima and Ballou, 
1975) and a 3,000 g supernatant of a yeast lysate ($3). After 
a 90-min incubation at 20°C, the 26-kD ER form of a-factor 
diminished in intensity when the high molecular weight spe- 
cies appeared (Fig. 3, lane 4). This conversion was not ob- 
served when the incubation was carried out at 0°C (Fig. 3, 
Figure L Morphology of yeast spheroplasts and permeabilized cells. 
Spheroplasts from wild-type cells (SFNY 26-66,, see Table I) are 
shown in C and permeabilized ceils are shown in A and B for com- 
parison. The small arrowhead points to a nucleus, the large arrow- 
head denotes a vacuole, and the asterisk (*) marks the lumen of 
the nuclear envelope. Bar, 0.5 Ixm. 
Table II. Amount of  Hexokinase  B and Carboxypeptidase  Y 
Remaining in the Permeabilized Cell Preparations 
Marker enzyme  Spheroplasts  Permeabilized cells  Supernatant 
%  %  % 
Hexokinase B  100  29  +  19  71  +  18 
Carboxypeptidase Y  100  81  +  5  19  +  5 
Spheroplasts were resuspended in permeabilization buffer and centrifuged at 
3,000  g  for  5  min.  The  levels  of hexokinase B  and  carboxypeptidase  Y 
(cytoplasmic and vacuolar enzyme markers, respectively)  were determined in 
intact spheroplasts, the permeabilized cell pellet and supernatant by quantita- 
tive Immunoblot analysis. The data in this table were the result of two separate 
experiments. 
The Journal of Cell Biology, Volume 107,  1988  1468 Figure 2.  Prepro-a-factor enters permeabilized  yeast cells (PYC) 
and is translocated.  In vitro translated prepro-ct-factor (A and B, 
lane 1 ) was incubated with permeabilized yeast cells (60 lag of pro- 
tein) for 20 min at 20°C  in the presence  of an ATP-regenerating 
system (A and B, lane 2).  (A) Samples were treated with trypsin 
(0.47 mg/ml) in the absence (lane 3) and presence (lane 4) of 0.1% 
Triton X-100. (B) At the end of the translocation reaction samples 
were centrifuged  in a microfuge for 15 s to generate  supernatant 
(S,) and pellet (P0 fractions. Prepro-et-factor was largely found in 
the supernatant  (A and B, lane 3),  while the majority  of the ER 
form of a-factor was in the pellet fraction with the permeabilized 
cells (A and B, lane 4). All samples were immunoprecipitated with 
anti-a-factor antibody raised against the secreted form of this pro- 
tein (Newman, A., and S. Ferro-Novick, unpublished results). Solu- 
bilized immunoprecipitates  were subjected to electrophoresis  in a 
12.5% NaDodSO4/polyacrylamide  slab gel and fluorographed. 
lane 2).  The areas of the gel containing the  19-kD, 26-kD, 
and  high  mol  wt  forms  of  a-factor  were  excised,  solu- 
bilized, and measured by scintillation counting. The increase 
in counts in the high molecular weight species (5,060 cpm) 
was largely accounted for by the decrease in counts in the 26- 
kD ER form of a-factor (3,750 cpm). Thus, the high molecu- 
lar weight species (5,060 cpm) was primarily a direct product 
of the 26-kD species. A small decrease in counts (650 cpm) 
in the 19-kD species was also observed, suggesting that some 
translocation had occurred. Since the total decrease in radio- 
activity in the 19-kD and 26-kD species was approximately the 
same as the increase in the high molecular weight form, a 
likely interpretation of the data is that the  19-kD primary 
translation  product  was  converted to  the  26-kD  ER  form 
which was the precursor to the high molecular weight form 
of a-factor. Conversion to the high molecular weight form of 
a-factor was efficient as shown by the fact that the ER form 
of a-factor diminished in intensity by ~54%  (Fig.  3, lanes 
1  and  4);  a  decrease of 48-66%  was generally observed. 
(The decrease in the ER form of a-factor was determined by 
densitometric scanning of lightly exposed autoradiograms). 
No requirement for GDP-mannose was seen (Fig. 3, lane 3), 
however, GDP-mannose was required when $3 fractions and 
permeabilized  cells  were  prepared  from  glucose  starved 
cells (not shown).  Enzymatic degradation of ATP with apy- 
rase (Fig. 3, lane 5) or hexokinase and glucose (not shown) 
Figure 3. The ER form of a-factor is converted to the high molecu- 
lar weight form in the presence of an $3 fraction and ATP. Permea- 
bilized yeast cells (60 lag of protein),  containing the ER form of 
a-factor, were incubated with an $3 fraction (0.7 mg of protein) and 
an ATP-regenerating system in the presence of GDP-mannose (lane 
4) or in its absence (lane 3).  No high molecular weight a-factor 
was detected when the sample was incubated on ice for 90 min (lane 
2), or when the incubation was performed in the absence of an $3 
fraction (lane 1 ). Depletion of ATP with apyrase (5 U/ml) inhibit- 
ed the reaction (lane 5). 
prevented the formation of the high molecular weight form 
of a-factor, indicating that ATP was required for this event. 
High Molecular Weight a-factor is in the Golgi Complex 
In vivo studies have shown that the high molecular weight 
species is the result of the addition of mannose units to the 
N-linked  oligosaccharide  chains  (Julius  et  al.,  1984a). 
These oligosaccharides are sensitive to digestion by Endo H, 
an  enzyme  that  cleaves  between  the  two N-acetylglucos- 
amine residues (Chu et al.,  1978).  To determine whether the 
shift in molecular weight observed in vitro was due to an ex- 
tension of N-linked oligosaecharide units,  we digested im- 
munoprecipitated  species  of  a-factor  with  Endo  H.  The 
results in Fig. 4 (lanes 3 and 4) demonstrate that high molec- 
ular  weight  a-factor was  sensitive to  digestion,  indicating 
that as observed in vivo, this increase in molecular weight 
was the result of the extension of N-linked carbohydrate and 
not to other posttranslational modifications. 
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gi complex. Permeabilized yeast cells, containing the ER form of 
a-factor, were incubated in the presence (lanes 3 and 4) or absence 
(lanes I and 2) of an $3 fraction. Samples were immunoprecipitated 
with a-factor antibody and then treated with Endo H (lanes 2 and 
4) as described  in Materials  and Methods.  In lanes 5 and 6, the 
in vitro transport assay was performed with permeabilized yeast cells 
and an $3 fraction prepared from a strain harboring the mnn2 mu- 
tation. At the end of the reaction, samples were immunoprecipitated 
with  a-factor antibody  and then subjected to a second immuno- 
precipitation with etl-6-Man antibody (lane 6). Solubilized immu- 
noprecipitates  were  subjected  to  electrophoresis  in  a  12.5% 
NaDodSodpolyacrylamide slab gel (lanes 1-6) and fluorographed. 
In lanes 7-10, the ER (lane 9) and Golgi forms (lane 10) of a-factor, 
synthesized in vitro, were compared with the forms of a-factor that 
accumulated in two different secretory mutants. The sec18 mutant 
(lane 7), blocks transport from the ER to the Golgi complex, and 
secl4 (lane 8) blocks transit through the Golgi apparatus. These mu- 
tants were radiolabeled  in vivo with [35S]sulfate at 37°C. Lysates 
were prepared as described in the Materials and Methods and im- 
munoprecipitated with a-factor antibody. Solubilized immunopre- 
cipitates were  subjected  to electrophoresis  in a  15%  NaDoSOd 
polyacrylamide  slab gel (lanes  7-10) and fluorographed. 
A detailed analysis of bulk glycoproteins in Saccharomyces 
cerevisiae has revealed the structure of these mannoproteins 
(Kukuruzinska et al.,  1987;  Ballou,  1982;  Trimble and At- 
kinson,  1986).  The inner core of N-linked oligosaccharide 
has the same structure as in mammalian cells and is added 
to glycoproteins in the lumen of the ER, while outer chain 
carbohydrate is added in the Golgi apparatus. The latter is 
a  highly branched structure consisting of 50-150 mannose 
residues. It has an etl-6-backbone with numerous sidechains 
attached in the ¢tl-2-1inkage  and terminal residues in the etl- 
3-linkage. Antibody directed against the ctl-6-Man backbone 
has been used to determine if an exported protein has ob- 
tained this Golgi-specific modification (Esmon et al.,  1981; 
Ferro-Novick et al., 1984). The ¢tl-6-Man antibody does not 
efficiently recognize the ctl-6-backbone unless this structure 
is devoid of sidechains.  In the yeast mnn2 mutant, manno- 
proteins lack these sidechains and the backbone is exposed 
(Ballou,  1982). To determine if the ctl-6-backbone had been 
added to the high molecular weight species, we prepared per- 
meabilized yeast cells and an $3 fraction from a strain har- 
boring the mnn2 mutation (see Table I). The high molecular 
weight species formed during the reaction was first immuno- 
precipitated with a-factor antibody (Fig. 4,  lanes 5  and 6) 
and then with antibody directed against the etl-6-Man back- 
bone  (Fig.  4,  lane  6).  As  seen in  Fig.  4,  high molecular 
weight a-factor was immunoprecipitated by the al-6 Man an- 
tibody, but not all of the heterogeneous material was recog- 
nized. This finding was not surprising since the antibody we 
used only recognizes long ctl-6-polymannose chains (Ballou 
et al., 1980). In addition, some of the high molecular weight 
a-factor recognized by the antibody was not readily observed 
(Fig. 4, lane 6), because IgG (50 kD) migrated in this region 
of the gel and quenched fluorographic detection. The speci- 
ficity of the al-6-Man antibody for outer chain carbohydrate 
was apparent since negligible amounts of the ER form of a-fac- 
tor were detected.  Although the transport reaction did not 
work well when fractions were prepared from the mnn2 mu- 
tant, high molecular weight u-factor was still seen (Fig. 4, 
lane 5). Since this species of a-factor was precipitated by an- 
tibody directed against the etl-6-Man backbone (Fig. 4, lane 
6), the high molecular weight form must have gained access 
to the Golgi complex to obtain this modification. 
To indirectly assess how far this proprotein had traversed 
the pathway in vitro, we compared the high molecular weight 
species detected in vitro with the form synthesized in vivo 
at the nonpermissive temperature (37°C) in sec14, a mutant 
that blocks protein transit in the Golgi complex (Novick et 
al.,  1981).  For this purpose cells were grown overnight at 
24°C,  shifted to 37°C  for  1 h,  and then pulse labeled for 
2  min with  [355]sulfate.  Radiolabeled cells were then har- 
vested, lysed, and incubated with a-factor antibody. As seen 
in Fig. 4, high molecular weight a-factor was not detected 
in vitro in the absence of an $3 fraction (lane 9) or in sec18 
(lane 7), a secretory mutant that blocks transit from the ER 
to the Golgi complex in vivo. However, the molecular weight 
of the proprotein detected in vitro, in the presence of an $3 
fraction,  was similar to the species synthesized at 37°C  in 
sec14 (Fig. 4, compare lanes 8 and 10). Although the gel sys- 
tem we normally used did not allow for the detection of the 
mature form of a-factor,  a  band which  migrated with the 
completely processed peptide  could  occasionally be  seen 
when gels were appropriately fixed. In 13 separate in vitro 
reactions  using  wild-type  cells  we  observed  this  peptide 
three times. The appearance of this species was dependent 
Figure 5.  Transport from the 
ER to the Golgi complex re- 
quires  sealed  compartments. 
The transport  assay was per- 
formed in the presence (lanes 
1-4) of an $3 fraction.  At the 
end  of the  reaction  samples 
were  incubated  with  trypsin 
(0.47 mg/ml) without (lane 2) 
or with (lane 3) 0.1% Triton 
X-100 (see Materials and Meth- 
ods). Triton X-100 (0.1%) was 
added to the sample in lane 4 
before the transport  assay. 
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this reaction was working at maximal efficiency, a minor por- 
tion of the prepro-a-factor appeared to be completely pro- 
cessed. Alternatively, the appearance of this peptide could 
be the result of nonspecific proteolysis. 
Transport of  a-factor  from the ER to the Golgi Complex 
Occurs Between Sealed Membrane Compartments 
When the transport product was incubated with trypsin, no 
degradation of the high molecular weight Golgi form or the 
26-kD ER form of or-factor was observed (Fig.  5, compare 
lanes 1 and 2), unless detergent was simultaneously added 
(Fig.  5,  lane 3).  In contrast,  most of the  19-kD primary 
translation product, which pelleted with the cells, was de- 
graded regardless of the presence of detergent (Fig. 5, com- 
pare lanes 2 and 3). These results indicated that both the ER 
and Golgi complex were intact after the transport reaction. 
Since the 19-kD primary translation product was accessible 
to protease in the absence of detergent, the permeabilized 
cells were not resealing during the assay.  No addition of 
outer chain carbohydrate was detected if sealed membrane 
compartments were disrupted during the reaction by the ad- 
dition of detergent (Fig. 5, lane 4). These findings indicate 
that the addition of outer chain carbohydrate to the ER form 
of ~t-factor requires the presence of sealed membrane com- 
partments. 
Transport from the ER to the Golgi Complex Requires 
Cytoplasm and Membranes from the $3 Fraction 
The $3 fraction, required to support transport to the Golgi 
complex,  contains  both  cytoplasm  and  membranes.  This 
fraction was subfractionated during a  100,000 g centrifuga- 
tion for 1 h to generate HSS and HSP fractions. Fig. 6 shows 
that neither fraction alone was sufficient to support transport 
(Fig. 6, lanes 2 and 3); however, when the two fractions were 
combined, activity was restored (Fig. 6, compare lanes I and 
4). In the presence of a fixed concentration of HSP, transport 
increased as the amount of HSS added to the reaction mix 
was increased (Fig. 6, lanes 4, 5, and 6). Conversely, when 
the concentration of HSS was maintained, the efficiency of 
the reaction was diminished as the amount of HSP added to 
the assay was decreased (not shown). 
To determine if proteins in both the HSS and HSP were 
required for transport, we treated each fraction with trypsin, 
inactivated the trypsin with trypsin inhibitor, and then added 
the remaining components to the assay mix. Since the factors 
present in each fraction were inactivated during this treat- 
ment (Fig. 7, compare lane 2 with lanes 3 and 4), we con- 
cluded that proteins in both the HSS and HSP were required 
for transport. Efficient transport was observed when trypsin 
was inactivated with trypsin inhibitor before incubation with 
either the HSS or HSP fractions (not shown). These studies 
indicate  that  both  soluble  and  membrane-bound  proteins 
are required for the in vitro transport of the 26-kD form of 
~t-factor to the Golgi complex in yeast. 
The Acceptor Compartment is Provided 
by the $3 Fraction 
To determine the identity of the HSP requirement, we have 
used the mnn9 mutant (see Table I) which is defective for the 
addition of outer chain carbohydrate to glycoprotein (Tsai et 
Figure 6. Factors in the cytoplasm and membranes are required for 
transport.  Transport was observed when wild-type permeabilized 
cells (60 lag of protein) were assayed (136.2 txl) in the presence of 
an $3 fraction (0.7 mg of protein) (lane 1 ). This supernatant was 
subfractionated at 100,000  g for 1 h to yield a high speed superna- 
tant (HSS) and high speed pellet (HSP). When either the HSS (0.4 
mg of protein) or HSP (0.3 mg of protein) was assayed, in the 
presence of wild-type permeabilized cells (60 lag of protein), little 
or no transport was observed (lanes 2 and 3); if these two fractions 
were combined (lane 4), activity was restored (compare lanes I and 
4). Transport to the Golgi complex was diminished if the concen- 
tration of HSS added to the reaction was decreased to 1/2 (lane 5) 
or 1/4 (lane 6). 
al., 1984). When a mnn9 $3 fraction was assayed in the pres- 
ence of wild-type permeabilized cells, the ER form of a-fac- 
tor was not converted to the high molecular weight species 
(Fig.  8,  lane 2).  Fractionation experiments indicated that 
soluble  factors isolated  from the mnn9 supernatant could 
support this conversion, when assayed in the presence of a 
wild-type HSP; however, the mutant $3 membrane fraction, 
when assayed in the presence of wild-type soluble factors, 
did not (not shown). This finding implies that the $3 fraction 
contains the acceptor membrane compartment that is respon- 
sible  for converting the  26-kD  species  of a-factor to  the 
Golgi form. 
The ER and Golgi Forms of  a-factor are 
Enriched in Separate Compartments 
After the first stage of the reaction the ER form of a-factor 
was predominantly retained within the permeabilized yeast 
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sensitive.  Permeabilized  yeast cells,  containing the  ER form of 
a-factor,  were assayed (136.2 ~tl total volume) in the absence (lane 
1) or presence (lane 2) of an $3 fraction.  HSS and HSP fractions 
generated from this $3 fraction were incubated with trypsin (1.2 ~tg 
of trypsin/50 Ixg HSS; 1 lag of trypsin/50 ~tg HSP) for 10 min on 
ice, trypsin inhibitor  was then added (8 Ixg), and the samples  were 
incubated  an additional  5 min.  Transport was blocked when the 
trypsin-treated  HSS was assayed  in the presence of an untreated 
HSP (lane 3); or, the trypsin-treated  HSP was assayed in the pres- 
ence of an untreated  HSS (lane  4).  Control experiments  demon- 
strated that efficient transport was observed when trypsin was inac- 
tivated with trypsin inhibitor, before incubation with either the HSS 
or HSP fractions (not shown). 
cells (Fig. 2 B). Our findings with the mnn9 mutant indicate 
that the functional acceptor must be added exogenously to 
the permeabilized cells. Based on this result one expectation 
is that, after the second stage of the reaction, the high molec- 
ular weight reaction product would be associated  with the 
exogenous  acceptor  rather  than  with  the  cells.  When  we 
pelleted the permeabilized cells for 15 s in a microfuge, after 
the transport assay, the high molecular weight form of a-fac- 
tor was recovered in the supernatant fraction and not in the 
pellet (Fig. 8, lanes 3 and 4). When the supernatant, contain- 
ing the Golgi form of a-factor, was recentrifuged for 5 min 
in a  microfuge the high molecular weight species was still 
recovered  in  the  supernatant.  Approximately  50%  of the 
NADPH cytochrome c  reductase activity, a  marker for the 
ER membrane (Kubota et al., 1977), pelleted during the 15-s 
centrifugation and an additional 25 % pelleted after 5 min of 
centrifugation.  Thus,  differential  centrifugation  separated 
most of the NADPH cytochrome c  reductase (~75 %) from 
the Golgi form of a-factor. The distribution of  the 26-kD spe- 
cies correlated with the distribution of NADPH cytochrome 
c reductase activity. As expected, most of the ER and Golgi 
forms of a-factor did pellet when the reaction product was 
centrifuged at 100,000 g for 1 h (Fig. 8, lanes 5 and 6). This 
finding  implied  that these  forms of ~t-factor were  retained 
within  membrane-bound  organelles  and  confirmed  earlier 
results  that had been obtained through protease  protection 
experiments  (Fig.  5). 
To further establish that the 26-kD species and Golgi form 
of a-factor reside in separate compartments, we centrifuged 
Figure 8.  The Golgi form of a-factor is in a sealed  compartment 
outside the permeabilized cells. Microsomes can serve as the donor 
compartment. The high molecular weight form of a-factor (lane 1 ) 
was detected  when wild-type permeabilized cells  were assayed  in 
the presence of a wild-type $3 fraction, but not if an $3 fraction 
was isolated  from a strain harboring the mmn9 mutation (lane 2). 
After the transport assay, a portion of the reaction product was cen- 
trifuged for 15 s in a microfuge and the forms of a-factor present 
in the  supernatant  and pellet  fractions were immunoprecipitated 
with a-factor antibody.  The Golgi form was found in the superna- 
rant (S~; lane 3) and not in the pellet (P1) with the permeabilized 
cells  (lane  4).  When  the  reaction  product  was  centrifuged  at 
100,000 g for 1 h in an ultracentrifuge,  the Golgi form of a-factor 
was found in the pellet (P2; lane 6) and not in the supernatant  ($2; 
lane 5).  In lanes  7 and 8, the transport assay was performed with 
microsomes instead  of permeabilized cells.  Prepro-a-factor was 
translocated  into  microsomes in a yeast translation  lysate.  After 
translocation, the lysate was supplemented  with an ATP-regenerat- 
ing system (1 mM ATP, 0.1 mM GTP, 20 mM creatine phosphate, 
and 0.2 mM creatine phosphate kinase)  and GDP-mannose (0.92 
mM). Samples were then incubated  for 90 min at 20°C in the ab- 
sence (lane  7) or presence (lane  8) of an $3 fraction. 
the reaction product in a 30-50% sucrose gradient to resolve 
these  species.  The  ER  form  of  a-factor  and  NADPH 
cytochrome c  reductase activity peaked in the pellet of this 
gradient.  In contrast, the Golgi form of a-factor peaked at 
a  concentration of 40-41%  sucrose (not shown).  Thus,  we 
have used  differential  centrifugation  and a  sucrose density 
gradient to demonstrate that the ER and Golgi forms of a- 
factor are enriched  in separate  compartments. 
The Donor Compartment Can be Provided by 
Microsomes Rather than Permeabilized Yeast Cells 
The addition of outer chain carbohydrate to the ER form of 
a-factor occurs in a compartment which does not fractionate 
with  the  permeabilized  cells.  Since  this  compartment  is 
provided by the  $3  fraction,  then  prepro-a-factor translo- 
cated into yeast microsomes, may be converted to the Golgi 
form in the presence of an $3 fraction. When this experiment 
was performed,  the addition of outer chain carbohydrate to 
the 26-kD species of a-factor was observed (Fig. 8, lane 8). 
This reaction required ATE since apyrase blocked this event 
(not shown).  Thus,  the donor can be provided in the form 
of microsomes rather than permeabilized  yeast cells. 
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but not Translocation 
It has recently been suggested that guanine nucleotide-bind- 
ing  proteins  participate  in  intracellular  protein  transport 
(Salminen and Novick, 1987;  Melancon et al.,  1987;  Goud 
et al.,  1988; Segev et al.,  1988). The nonhydrolyzable GTP 
analog GTPyS has been shown to inhibit transport through 
the  Golgi  in  vitro  causing  the  accumulation  of vesicles 
(Melancon  et al.,  1987).  As  seen in  Fig.  9,  1  x  10  -4 M 
GTPTS can inhibit transport from the ER to the Golgi com- 
plex in vitro. Low concentrations of GTPTS (1  x  10  -5 M) 
also affect transport.  These affects were partially reversible 
if 1 mM GTP was added with GTPyS at the beginning of the 
reaction. When  1  ×  10  -4 M  GTPyS was added during the 
first stage of the reaction no affect on translocation was ob- 
served (Fig.  9,  compare lanes 4  and 5).  Thus,  GTPTS in- 
hibits the second stage but not the first stage of this two stage 
reaction. 
The Acceptor Compartment is Defective 
in the sec23 Mutant 
The authenticity of the transport reaction can be tested by 
using secretory mutants that have been shown to block trans- 
port from the ER to the Golgi complex in vivo. To initiate 
an analysis of a sec gene product in this reaction, we tested 
in vitro fractions (an $3 fraction and permeabilized cells) de- 
rived from sec23 (see Table I), a mutant that blocks ER to 
Golgi transport  in  vivo at  37°C.  Fractions  were prepared 
from mutant cells that were incubated at the restrictive tem- 
perature in vivo by following the protocol we developed to 
reconstitute transport with wild-type cells.  When this was 
done transport was completely blocked if sec23 permeabi- 
lized cells were assayed in the presence ofa sec23 $3 fraction 
(Fig.  10 B, lane 3). 
Since the  function of donor,  acceptor,  and soluble frac- 
tions can be assayed separately, we proceeded to determine 
which fraction is defective in the sec23 mutant. When an $3 
fraction, isolated from this mutant, was assayed in the pres- 
ence of wild-type permeabilized cells (Fig.  10 A,  lane 2) 
transport failed to occur. However, permeabilized sec23 cells 
were capable of supporting transport when assayed in the 
presence of a wild-type $3 fraction, but were less effective 
than wild-type cells (Fig.  10 B, lane 2). Not all functions of 
the ER membrane were effected in sec23, since mutant per- 
meabilized cells could efficiently translocate prepro-tx-factor 
into the lumen of the ER (not shown). The diminished capac- 
ity of the donor compartment may be a  secondary conse- 
quence of shifting the mutant in vivo. This possibility is dis- 
cussed below. 
To determine whether a soluble or membrane-bound fac- 
tor in the $3 fraction of sec23 is defective, this supernatant 
was centrifuged at  100,000  g  for  1 h  to generate HSS and 
HSP fractions. Mutant HSS in combination with a wild-type 
HSP effectively supported transport in wild-type perrneabi- 
lized cells (Fig.  11, compare lanes I  and 2). However, a mu- 
tant HSP assayed in the presence of a wild-type HSS failed 
to support transport (Figure  11, lane 3).  These results indi- 
cate that the sec23 mutant is defective in a component that 
is normally provided by the HSP. Findings described above 
suggest  that  the  acceptor membrane compartment is pro- 
vided by this fraction. 
Since  the sec23  mutant was incubated at the  restrictive 
temperature before fractions were prepared, the phenotype 
we observed in vitro may be a secondary consequence of this 
incubation.  Therefore, we repeated these experiments with 
Figure 9. GTPTs inhibits transport.  Wild-type permeabilized cells, 
containing the 26-kD form of a-factor, were incubated without (lane 
1) or with an $3 fraction in the absence (lane 2) or presence (lane 
3) of 1 ×  10  -4 M GTP3,S. In vitro translated prepro-ct-factor was 
incubated with permeabilized yeast cells in the absence (lane 4) or 
presence (lane 5) of 1 x  10  -4 M GTP-/S. 
Figure 10. An $3 fraction from sec23 does not support transport. 
(A) Wild-type  permeabilized  cells,  containing  radiolabeled  pro- 
protein in the lumen of the ER, were incubated in the presence of 
a wild-type (lane 1) or sec23 $3 fraction (lane 2).  (B) Permeabi- 
lized sec23 cells,  containing  radiolabeled  proprotein  in the ER, 
were incubated in the absence (lane 1) or the presence of a wild- 
type $3 fraction (lane 2). Permeabilized sec23 cells did not support 
transport  when incubated with a sec23 $3 fraction  (lane 3). 
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sec23. A sec23 $3 fraction was centrifuged at 100,000 g for 1 h to 
generate HSS and HSP fractions that were assayed (136.2 ~tl total 
reaction volume) for activity in the presence of  wild-type permeabi- 
lized cells  (60  Ixg of protein).  A sec23 HSS (0.4 mg of protein) 
effectively supported transport to the Golgi complex, when assayed 
in the presence of a wild-type HSP (compare lanes 1 and 2). How- 
ever, a sec23 HSP (0.3 mg of protein) failed to transport  the ER 
form of a-factor, when assayed in the presence of wild-type HSS 
(compare lanes I and 3). No transport was observed if the HSS and 
HSP fractions were both isolated from the sec23 mutant and as- 
sayed in the presence  of wild-type permeabilized  cells (lane 4). 
fractions generated from ceils that were only incubated at the 
permissive temperature in vivo. Using these fractions we ob- 
served that the acceptor compartment was defective for trans- 
port while the donor and soluble fractions were fully func- 
tional  (not  shown).  Further  experiments  will  be  needed 
before the effects observed on the donor compartment, after 
an in vivo shift,  can be evaluated. 
Discussion 
In vitro assays that faithfully reproduce the stages of intracel- 
lular protein transport will lead to the identification of com- 
ponents that are essential for these processes. The character- 
ization of such components will be facilitated by an analysis 
of these  events  in  an  organism  that  is  amenable  to  both 
genetic and biochemical manipulation. In this report, we de- 
scribe  a  new  assay  that  efficiently reconstitutes  transport 
from the ER to the Golgi complex in yeast. This assay and 
the  existence  of  a  large  collection  of  mutants  that  are 
temperature-sensitive for the transport of proteins between 
these organelles (Novick et al.,  1980;  Newman and Ferro- 
Novick, 1987) should expedite an analysis of this stage of the 
secretory pathway. We report here that the acceptor compart- 
ment is defective in one of these mutants, sec23. 
Requirements for Transport 
A unique feature of our in vitro system is the coupled use of 
translocation across the ER membrane and transport to the 
Golgi complex using the pheromone a-factor as a  marker 
protein. By in vitro translating prepro-(x-factor in a yeast ly- 
sate,  we  can  easily  obtain  a  radiolabeled  protein  of high 
specific radioactivity. Radiolabeled prepro-Q-factor is trans- 
located directly into microsomes or into the ER lumen re- 
tained within permeabilized yeast cells. Protein sequestered 
within the lumen is then transported to the Golgi apparatus 
in the presence of ATP and an $3 fraction, that contains solu- 
ble and membrane-bound components (Fig.  3,  lanes 4 and 
5). The assay we developed differs from the mammalian ER 
to Golgi in vitro transport assay described by Beckers et al. 
(1987)  in that we introduce radiolabeled marker protein into 
the lumen of the ER in vitro during translocation rather than 
in vivo during virus infection. Our assay also differs from the 
mammalian system (Beckers et al.,  1987; Simons and Virta, 
1987)  in that the acceptor Golgi compartment must always 
be provided exogenously to the permeabilized cells. 
Transport to the Golgi complex in vitro requires the addi- 
tion of acceptor compartments supplied by the $3 fraction. 
This was demonstrated by the failure of the mnn9 $3 fraction 
to support outer chain elongation (Fig. 8, lane 2). Therefore, 
if acceptor membranes are present in the permeabilized cells 
they are not used.  The $3  fraction and the  permeabilized 
cells are prepared differently (see Materials and Methods). 
Thus,  the  conditions  used  to prepare permeabilized yeast 
cells may lead to inactivation or loss of.the acceptor compart- 
ments.  Although  we  have shown  that  permeabilized cells 
serve as an efficient donor in this reaction, they are not essen- 
tial. When an $3 fraction and ATP are added to yeast micro- 
somes, containing  the 26-kD  species of a-factor, the high 
molecular weight Golgi form is produced. 
We have shown that GTP'tS can inhibit ER to Golgi trans- 
port in vitro (Fig. 9). Inhibition of transport by GTP),S has 
been used by others (Melancon et al.,  1987) to implicate the 
involvement of a GTP-binding protein in inter-Golgi trans- 
port.  One proposal is that this protein functions in a  cycle 
in which the GTP-bound form of the protein binds to a site 
on  a  transport vesicle.  This  complex is  recognized by an 
effector on the acceptor compartment, triggering membrane 
fusion. Release of the GTP-binding protein is coupled to hy- 
drolysis of GTP. GTP),S disrupts the system because it can- 
not be hydrolyzed. Recently it has been shown that mutations 
in the GTP-binding protein yptl can affect ER to Golgi trans- 
port in yeast (Segev et al.,  1988; Schmitt et al.,  1988). Fur- 
ther experiments will be needed before one can conclude if 
Yptl or another GTP-binding protein mediates the effects of 
GTP~/S. 
The addition of outer chain carbohydrate to core glycosyl- 
ated invertase has previously been reported to occur in yeast 
homogenates at a efficiency of 2-5 % (Haselbeck and Schek- 
man,  1986).  This reaction was attributed to transport from 
The Journal of Cell Biology, Volume 107, 1988  1474 the ER to the Golgi complex and showed an absolute depen- 
dence on manganese chloride (5 mM), but did not require 
the addition of a soluble factor(s). Our present reaction con- 
ditions require a soluble component(s) but does not require 
manganese chloride. If our assay is performed in the pres- 
ence of 5  mM manganese chloride, the addition of outer 
chain carbohydrate to the ER form of ~t-factor is not depen- 
dent on the presence of ATP.  Since an energy requirement 
for transport from the ER to the Golgi complex has been 
demonstrated in vivo (Jamieson and Palade,  1968; Novick 
et al., 1981; Balch et al., 1986), the reaction in the presence 
of high concentrations of manganese chloride is unlikely to 
be authentically reconstituting in vivo events. 
Intercompartraental  Transport 
Two possibilities could account for the formation of the high 
molecular weight form of a-factor. It could be the result of 
authentic intercompartmental transport from the ER to the 
Golgi complex.  Alternatively,  translocation of the  19-kD 
form of a-factor into a fused compartment in the $3 fraction 
or fusion of the Golgi complex with the ER after transloca- 
tion could occur. Four lines of evidence establish that we are 
studying  intercompartmental  transport.  First,  differential 
centrifugation and fractionation on a  sucrose density gra- 
dient have shown that the ER and Golgi forms of a-factor are 
enriched in separable compartments which are therefore un- 
likely to be fused. Second, GTP~S does not inhibit the for- 
mation of the 26-kD species but does inhibit conversion to 
the high molecular weight species. This result is inconsistent 
with the possibility that the  19-kD species is translocated 
into a fused compartment in the $3 fraction. Third, permea- 
bilized cells, prepared from one of the mutants that block 
transport from the ER to the Golgi complex in vivo, contain 
defective donor membranes and fail to convert the 26-kD 
form of a-factor to the high molecular weight species when 
assayed in the presence of an active wild-type $3 fraction. 
This indicates that, in the absence of functional permeabi- 
lized cells, the wild-type $3 fraction is not capable of cou- 
pled translocation, core glycosylation, and outer chain addi- 
tion of the residual  19-kD form of a-factor retained in the 
ceils. Because formation of the high molecular weight form 
is dependent on the nature of the permeabilized cells, the 26- 
kD ER form of a-factor associated with the permeabilized 
cells is a  necessary intermediate in transport to the Golgi 
complex in vitro. Fourth, the quantitation of the data in Fig. 
3 indicates that conversion to the high molecular weight form 
of a-factor formed in  the  second stage of the  reaction is 
largely due to the depletion of 26-kD  species of a-factor 
formed in the first stage. This indicates that most of  the a-fac- 
tor which is converted to the high molecular weight form 
resided in the ER before transport to the Golgi apparatus. 
Analysis of  a Secretory Mutant in the In Vitro Assay 
An analysis of the sec23 mutant has shown that a defect in 
the Sec23 protein inactivates the acceptor compartment (Fig. 
11, compare lanes 2 and 3). The acceptor fraction, isolated 
from permissively grown sec23 mutant cells is defective for 
transport when assayed at 20°C. Therefore, it is possible that 
the Golgi complex may be partially defective in vivo even at 
the permissive temperature. This defect may be rate limiting 
in vitro at 20°C, but may not be limiting in vivo. While our 
results do not necessarily imply that the SEC23 gene product 
is a component of the Golgi complex, loss of Sec23 protein 
activity leads to failure of acceptor function either directly, 
through interaction with the Golgi complex, or through a se- 
ries of biochemical reactions. Because the in vitro delivery 
of prepro-a-factor to the Golgi complex is SEC dependent, 
it is likely that transport is occurring in a manner that reflects 
normal vectorial flow. 
Future Uses of the In Vitro Assay 
Because our assay allows us to separate the donor, acceptor, 
and soluble fractions we have been able to demonstrate a de- 
fect in the acceptor compartment of the sec23 mutant. The 
analysis we have done with this mutant can be extended to 
the other sec and bet mutants that disrupt transit at this stage 
of the pathway.  This will enable us to determine which frac- 
tion is defective in each of the secretory mutants.  A  com- 
bined genetic and  biochemical approach  will  lead  to the 
identification of proteins that play a  role in this process. 
Some of these components, however, may not be represented 
among the known SEC or BET gene products. The in vitro 
transport assay may permit the purification and characteriza- 
tion of proteins involved in this event and the genetic flexibil- 
ity of yeast will enable us to address their role in vivo. In ad- 
dition, since the processing of prepro-a-factor to the mature 
form is thought to begin in a late Golgi compartment, with 
further optimization this assay may be extended to  study 
intra-Golgi transport in yeast. 
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